|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-4-30
|
|
pubmed:abstractText |
A recent report of the combination of gemcitabine and docetaxel described favorable results in patients with uterine leiomyosarcoma. The objective of this report is to describe experience with this combination in a variety of histologic subtypes of sarcoma. Additionally, cell-culture studies were performed to assess the effect of the sequence of drug administration on colony formation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1706-12
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15117993-Adult,
pubmed-meshheading:15117993-Aged,
pubmed-meshheading:15117993-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15117993-Bone Neoplasms,
pubmed-meshheading:15117993-Deoxycytidine,
pubmed-meshheading:15117993-Drug Administration Schedule,
pubmed-meshheading:15117993-Drug Interactions,
pubmed-meshheading:15117993-Female,
pubmed-meshheading:15117993-Humans,
pubmed-meshheading:15117993-Infusions, Intravenous,
pubmed-meshheading:15117993-Male,
pubmed-meshheading:15117993-Middle Aged,
pubmed-meshheading:15117993-Retrospective Studies,
pubmed-meshheading:15117993-Sarcoma,
pubmed-meshheading:15117993-Soft Tissue Neoplasms,
pubmed-meshheading:15117993-Taxoids
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.
|
|
pubmed:affiliation |
Department of Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.
|
|
pubmed:publicationType |
Journal Article
|
